On the afternoon of April 10, Chen Yujian and several government leaders of Minhang District as well as a BGI delegation led by Wang Jian visited the Minhang Base of the National Facility for Translational Medicine (“The Translational Medicine Facility”). Mao Junfa received the guests on behalf of SJTU.
Mao firstly introduced that after the resumption of work and production in early March, the Translational Medicine Facility has been steadily promoting its operation based on the strict implementation of relevant preventive and control measures.
Zhang Xianming, Director of the Specialized Construction Office, introduced the basic construction and operation plan of the Translational Medicine Facility and said that SJTU and its affiliated hospitals have actively responded to the national innovation strategy of “Healthy China” and promote the building of a large platform for medicine-industry integrated research. The Translational Medicine Facility focuses on clinical medicine, drugs, medical materials, and biomedical manufacturing, forming a multi-level and multi-dimensional open sharing system of instruments and equipment, technical services, shared laboratories, open topics, and scientific popularization, and focusing on major theoretical, practical and scientific problems facing the development of the health industry, to contribute to overcoming major human diseases.
Zhang Zhaoguo, Director of the Instrumental Analysis Center led the experts to visit the public instrument platforms such as the Electron Microscopy and Imaging Center, the NMR Center, the Mass Spectrometry and Spectroscopy Platforms to further explain the construction of the Translational Medicine Facility. Afterward, they visited the users sharing laboratories of biomedical information and manufacturing. The two sides then had an in-depth discussion on their cooperation intention as well as the operation mode, development, and results transformation of the user workstation of the National Center for Metabolic Diseases-BGI Joint Sequencing Center.
